AFDN and neoplasm: We found 11q23.3-25 amplification in 10 samples (5.3%), among which four tumors (2.1%) showed amplification of the whole chromosome, one tumor (0.5%) contained a MLL/MLLT4 fusion associated with amplification of the chromosomal region 3′ of MLL, and five tumors (2.7%) displayed partial amplification of chromosome 11 (chr.11) that includes 11q23.3-25 (Figures 4B, 4C, and S8).